Symbol="SLS"
AssetType="Common Stock"
Name="Sellas Life Sciences Group Inc"
Description="SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the United States. The company is headquartered in New York, New York."
CIK="1390478"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="310 N. STATE STREET, SUITE 208, LAKE OSWEGO, OR, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="43372300"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.465"
DividendPerShare="0"
DividendYield="0"
EPS="-1.46"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.903"
ReturnOnEquityTTM="-4.147"
RevenueTTM="0"
GrossProfitTTM="900000"
DilutedEPSTTM="-1.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.825"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="47.76"
PriceToBookRatio="3.792"
EVToRevenue="27.45"
EVToEBITDA="-0.622"
Beta="2.289"
num_52WeekHigh="5.58"
num_52WeekLow="1.17"
num_50DayMovingAverage="1.655"
num_200DayMovingAverage="2.239"
SharesOutstanding="28347900"
DividendDate="2019-11-08"
ExDividendDate="None"
symbol="SLS"
open="1.63"
high="1.65"
low="1.52"
price="1.53"
volume="142015.00"
latest_trading_day="2023-08-04"
previous_close="1.62"
change="-0.09"
change_percent="-5.5556%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="196456"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="1151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_negative_thumbnail_id_2="157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0019.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="703"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
